MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 74 filers reported holding MEI PHARMA INC in Q2 2019. The put-call ratio across all filers is 2.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $38,000 | -75.3% | 63,485 | +10.2% | 0.00% | -100.0% |
Q4 2021 | $154,000 | -6.1% | 57,612 | -2.9% | 0.00% | 0.0% |
Q3 2021 | $164,000 | -5.2% | 59,336 | -2.3% | 0.00% | 0.0% |
Q2 2021 | $173,000 | -21.0% | 60,746 | -5.0% | 0.00% | 0.0% |
Q1 2021 | $219,000 | +30.4% | 63,921 | +0.3% | 0.00% | 0.0% |
Q4 2020 | $168,000 | -13.0% | 63,752 | +3.2% | 0.00% | 0.0% |
Q3 2020 | $193,000 | -26.1% | 61,779 | -2.2% | 0.00% | 0.0% |
Q2 2020 | $261,000 | +169.1% | 63,183 | +5.3% | 0.00% | 0.0% |
Q1 2020 | $97,000 | -11.0% | 59,983 | +36.0% | 0.00% | – |
Q4 2019 | $109,000 | +51.4% | 44,089 | +2.5% | 0.00% | – |
Q3 2019 | $72,000 | -33.9% | 43,032 | -0.7% | 0.00% | – |
Q2 2019 | $109,000 | -99.9% | 43,332 | +428.2% | 0.00% | – |
Q1 2014 | $91,299,000 | +42.4% | 8,203 | +2.5% | 0.00% | – |
Q4 2013 | $64,128,000 | -12.2% | 8,006 | +24.3% | 0.00% | – |
Q3 2013 | $73,030,000 | – | 6,440 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 826,913 | $1,737,000 | 0.98% |
ALGERT GLOBAL LLC | 233,894 | $491,000 | 0.12% |
WITTENBERG INVESTMENT MANAGEMENT, INC. | 50,399 | $106,000 | 0.05% |
SHEPHERD KAPLAN KROCHUK, LLC | 20,000 | $42,000 | 0.03% |
Ancora Advisors LLC | 167,462 | $352,000 | 0.02% |
OXFORD ASSET MANAGEMENT LLP | 331,078 | $685,000 | 0.02% |
KNOTT DAVID M | 14,000 | $29,000 | 0.01% |
Transform Wealth, LLC | 30,355 | $64,000 | 0.01% |
ClariVest Asset Management LLC | 201,700 | $423,000 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 189,947 | $399,000 | 0.01% |